H1 healthcare deal rebound leaves PE investors ‘cautiously optimistic,’ says Bain & Company’s Nirad Jain

'If you look at buyout value, 2024 in North America is probably on trend for being one of the top three or four deal years of all time from a healthcare value perspective.'